These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34982304)

  • 21. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
    Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
    Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
    Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
    J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
    Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
    Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory Complications in Patients with Hyper IgM Syndrome.
    Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
    J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD40 Ligand Deficiency.
    Leite LFB; Máximo TA; Mosca T; Forte WCN
    Allergol Immunopathol (Madr); 2020; 48(4):409-413. PubMed ID: 31831191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ.
    Cabral-Marques O; França TT; Al-Sbiei A; Schimke LF; Khan TA; Feriotti C; da Costa TA; Junior OR; Weber CW; Ferreira JF; Tavares FS; Valente C; Di Gesu RSW; Iqbal A; Riemekasten G; Amarante-Mendes GP; Marzagão Barbuto JA; Costa-Carvalho BT; Pereira PVS; Fernandez-Cabezudo MJ; Calich VLG; Notarangelo LD; Torgerson TR; Al-Ramadi BK; Ochs HD; Condino-Neto A
    J Allergy Clin Immunol; 2018 Nov; 142(5):1571-1588.e9. PubMed ID: 29518426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic stem cell transplantation in CD40 ligand deficiency: A single-center experience.
    Uygun DFK; Uygun V; Karasu GT; Daloğlu H; Öztürkmen SI; Çelmeli F; Törün SH; Özen A; Barış S; Aydıner EK; Yalçın K; Kılıç SÇ; Hazar V; Bingöl A; Yeşilipek A
    Pediatr Transplant; 2020 Sep; 24(6):e13768. PubMed ID: 32573870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
    DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
    Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infectious Complications Predict Premature CD8
    Shin JJ; Catanzaro J; Yonkof JR; Delmonte O; Sacco K; Shin MS; Reddy S; Whittington PJ; Soffer G; Mustillo PJ; Sullivan KE; Notarangelo LD; Abraham RS; Romberg N; Kang I
    J Clin Immunol; 2021 May; 41(4):795-806. PubMed ID: 33495902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
    Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity.
    Günaydin NC; Chou J; Karaca NE; Aksu G; Massaad MJ; Azarsiz E; Ertan Y; Geha RS; Kütükçüler N
    Clin Immunol; 2014 Aug; 153(2):288-91. PubMed ID: 24845792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases.
    Zelazko M; Carneiro-Sampaio M; Cornejo de Luigi M; Garcia de Olarte D; Porras Madrigal O; Berrón Perez R; Cabello A; Rostan MV; Sorensen RU
    J Clin Immunol; 1998 Mar; 18(2):161-6. PubMed ID: 9533660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
    Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
    Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
    Hubbard N; Hagin D; Sommer K; Song Y; Khan I; Clough C; Ochs HD; Rawlings DJ; Scharenberg AM; Torgerson TR
    Blood; 2016 May; 127(21):2513-22. PubMed ID: 26903548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
    Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
    Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary immunodeficiency diseases in Latin America: proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory Board.
    Leiva LE; Bezrodnik L; Oleastro M; Condino-Neto A; Costa-Carvalho BT; Grumach AS; Espinosa-Rosales FJ; Franco JL; King A; Inostroza J; Quezada A; Porras O; Sorensen RU
    Allergol Immunopathol (Madr); 2011; 39(2):106-10. PubMed ID: 21345576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
    Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
    Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.
    Allen RC; Armitage RJ; Conley ME; Rosenblatt H; Jenkins NA; Copeland NG; Bedell MA; Edelhoff S; Disteche CM; Simoneaux DK
    Science; 1993 Feb; 259(5097):990-3. PubMed ID: 7679801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished CD40L expression on T-cells in a case of disseminated cryptococcosis.
    Mohanty SK; Thakral D; Gupta D; Kumar P; Mitra DK
    Indian J Pathol Microbiol; 2018; 61(1):137-140. PubMed ID: 29567905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.